Showing results (841-850 of 5,219) with videos related to
Sort By:
Pageof 522
Antiviral Research|November 1, 1987
Herpes simplex virus as an inducer of interferon in human monocyte culturesK Linnavuori, T HoviAntiviral Research|June 12, 2012
No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patientsFederico Alejandro Di Lello, Juan Macias, Zulema Plaza, et al.Antiviral Research|November 21, 2012
Catheterized guinea pigs infected with Ebola Zaire virus allows safer sequential sampling to determine the pharmacokinetic profile of a phosphatidylserine-targeting monoclonal antibodyStuart Dowall, Irene Taylor, Paul Yeates, et al.Antiviral Research|March 26, 2013
A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a modelClara Ramírez, Josep Gregori, Maria Buti, et al.Antiviral Research|March 26, 2013
Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challengeBrian B Gowen, Kevin W Bailey, Dionna Scharton, et al.Antiviral Research|April 10, 2012
Viral genome RNA degradation by sequence-selective, nucleic-acid hydrolyzing antibody inhibits the replication of influenza H9N2 virus without significant cytotoxicity to host cellsAeyung Kim, Ja-Yeong Lee, Sung June Byun, et al.Antiviral Research|September 28, 2014
(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytesHsiu-Chen Huang, Mi-Hua Tao, Tzu-Min Hung, et al.Antiviral Research|September 8, 2014
Pathophysiology of a severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibantAntti Vaheri, Tomas Strandin, Anne J Jääskeläinen, et al.Antiviral Research|September 9, 2014
A tribute to Sheik Humarr Khan and all the healthcare workers in West Africa who have sacrificed in the fight against Ebola virus disease: Mae we hushDaniel G Bausch, James Bangura, Robert F Garry, et al.Antiviral Research|August 10, 2014
Nitazoxanide: a first-in-class broad-spectrum antiviral agentJean-François RossignolPageof 522